Sage Mountain Advisors LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 24 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Sage Mountain Advisors LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q2 2022$860,000
-7.8%
86,890
-8.2%
0.15%
+4.1%
Q1 2022$933,000
-3.2%
94,640
-2.1%
0.15%
+25.9%
Q4 2021$964,000
-1.3%
96,640
-2.0%
0.12%
-17.7%
Q3 2021$977,000
-0.2%
98,620
+2.8%
0.14%
-13.0%
Q2 2021$979,000
+1.5%
95,9700.0%0.16%
-21.0%
Q1 2021$965,000
-5.7%
95,9700.0%0.20%
-38.8%
Q4 2020$1,023,00095,9700.34%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 248,674$2,452,0000.81%
Wealthspring Capital LLC 138,373$1,365,0000.27%
Cowen Investment Management LLC 100,000$986,0000.21%
Integrity Capital Management (HK) Ltd 3,800$37,0000.19%
Sage Mountain Advisors LLC 94,640$933,0000.15%
Schechter Investment Advisors, LLC 82,802$816,0000.08%
Verition Fund Management LLC 397,603$3,928,0000.05%
Magnetar Financial LLC 450,000$4,446,0000.05%
HGC Investment Management Inc. 79,150$781,0000.05%
RIVERNORTH CAPITAL MANAGEMENT, LLC 75,650$747,0000.03%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders